<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim MJ</submitter><funding>Ministry of Health and Welfare, Korea</funding><funding>Ministry of Health &amp;amp; Welfare, Republic of Korea</funding><funding>Korea Association of Health Promotion</funding><funding>National Research Foundation of Korea</funding><pagination>2812</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9687185</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(11)</volume><pubmed_abstract>Toxoplasmosis diagnosis predominantly relies on serology testing via enzyme-linked immunosorbent assay (ELISA), but these results are highly variable. Consequently, various antigens are being evaluated to improve the sensitivity and specificity of toxoplasmosis serological diagnosis. Here, we generated &lt;i>Toxoplasma gondii&lt;/i> virus-like particles displaying AMA1 of &lt;i>T. gondii&lt;/i> and evaluated their diagnostic potential. We found that AMA1 VLPs were highly sensitive and reacted with the sera acquired from mice infected with either &lt;i>T. gondii&lt;/i> ME49 or RH strains. The overall IgG and IgM antibody responses elicited by AMA1 VLPs were substantially higher than those induced by the conventionally used &lt;i>T. gondii&lt;/i> lysate antigen (TLA). Importantly, AMA1 VLPs were capable of detecting parasitic infection with &lt;i>T. gondii&lt;/i> RH and ME49 as early as 1 week post-infection, even when mice were exposed to low infectious doses (5 × 10&lt;sup>3&lt;/sup> and 10 cysts, respectively). AMA1 VLPs also did not cross-react with the immune sera acquired from &lt;i>Plasmodium berghei&lt;/i>-infected mice. Compared to TLA, stronger antibody responses were induced by AMA1 VLPs when tested using &lt;i>T. gondii&lt;/i>-infected human sera. The sensitivities and specificities of the two antigens were substantially different, with AMA1 VLPs demonstrating over 90% sensitivity and specificity, whereas these values were in the 70% range for the TLA. These results indicated that AMA1 VLPs can detect infections of both &lt;i>T. gondii&lt;/i> ME49 and RH at an early stage of infection caused by very low infection doses in mice, and these could be used for serological diagnosis of human toxoplasmosis.</pubmed_abstract><journal>Biomedicines</journal><pubmed_title>Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of &lt;i>Toxoplasma gondii&lt;/i> Infection.</pubmed_title><pmcid>PMC9687185</pmcid><funding_grant_id>2018R1A6A1A03025124</funding_grant_id><funding_grant_id>2020-01</funding_grant_id><funding_grant_id>HV20C0085, HV20C0142</funding_grant_id><funding_grant_id>NRF-2018-R1A6A1A03025124</funding_grant_id><funding_grant_id>HV20C0142</funding_grant_id><funding_grant_id>HV20C0085</funding_grant_id><pubmed_authors>Chu KB</pubmed_authors><pubmed_authors>Yoon KW</pubmed_authors><pubmed_authors>Kang HJ</pubmed_authors><pubmed_authors>Quan FS</pubmed_authors><pubmed_authors>Eom GD</pubmed_authors><pubmed_authors>Lee SH</pubmed_authors><pubmed_authors>Kim MJ</pubmed_authors><pubmed_authors>Moon EK</pubmed_authors><pubmed_authors>Lee YH</pubmed_authors><pubmed_authors>Mao J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of &lt;i>Toxoplasma gondii&lt;/i> Infection.</name><description>Toxoplasmosis diagnosis predominantly relies on serology testing via enzyme-linked immunosorbent assay (ELISA), but these results are highly variable. Consequently, various antigens are being evaluated to improve the sensitivity and specificity of toxoplasmosis serological diagnosis. Here, we generated &lt;i>Toxoplasma gondii&lt;/i> virus-like particles displaying AMA1 of &lt;i>T. gondii&lt;/i> and evaluated their diagnostic potential. We found that AMA1 VLPs were highly sensitive and reacted with the sera acquired from mice infected with either &lt;i>T. gondii&lt;/i> ME49 or RH strains. The overall IgG and IgM antibody responses elicited by AMA1 VLPs were substantially higher than those induced by the conventionally used &lt;i>T. gondii&lt;/i> lysate antigen (TLA). Importantly, AMA1 VLPs were capable of detecting parasitic infection with &lt;i>T. gondii&lt;/i> RH and ME49 as early as 1 week post-infection, even when mice were exposed to low infectious doses (5 × 10&lt;sup>3&lt;/sup> and 10 cysts, respectively). AMA1 VLPs also did not cross-react with the immune sera acquired from &lt;i>Plasmodium berghei&lt;/i>-infected mice. Compared to TLA, stronger antibody responses were induced by AMA1 VLPs when tested using &lt;i>T. gondii&lt;/i>-infected human sera. The sensitivities and specificities of the two antigens were substantially different, with AMA1 VLPs demonstrating over 90% sensitivity and specificity, whereas these values were in the 70% range for the TLA. These results indicated that AMA1 VLPs can detect infections of both &lt;i>T. gondii&lt;/i> ME49 and RH at an early stage of infection caused by very low infection doses in mice, and these could be used for serological diagnosis of human toxoplasmosis.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-18T20:31:02.554Z</modification><creation>2025-04-07T08:20:10.654Z</creation></dates><accession>S-EPMC9687185</accession><cross_references><pubmed>36359332</pubmed><doi>10.3390/biomedicines10112812</doi></cross_references></HashMap>